RT3

Reta is a synthetic peptide engineered as a triple receptor agonist. It targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors in experimental systems.

Unlike single-pathway peptides, Reta is designed to engage multiple metabolic pathways. Its extended amino acid sequence, along with specific substitutions such as α-aminoisobutyric acid (Aib) residues, enhances structural stability and receptor interaction in controlled research environments.

In laboratory and preclinical studies, Reta is investigated for its ability to activate interconnected endocrine signaling networks. It helps researchers explore how coordinated receptor activation influences glucose metabolism, lipid regulation, energy expenditure, and hormonal communication in cellular and animal models.

Product Details

Available Sizes: 10mg, 20mg, 30 mg, 50 mg, 60 mg

Format: Lyophilized powder

Appearance: White to off-white powder in a sealed research vial

Composition: Single-component peptide research material

Testing Focus: HPLC / LC-MS identity and purity assessment, when applicable

Research Focus

RT3 may be used in non-clinical research settings focused on:

Peptide identity and purity assessment using HPLC or LC-MS methodsChromatographic method development and impurity profilingStability characterization of lyophilized peptide material under laboratory storage conditionsAssay development and calibration for receptor-related model systems Quantitative analysis and method validation in controlled research environments

Research Use Only

This product is sold for research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Storage: Keep lyophilized powder cool/dry. Refrigerate after reconstitution.